Welcome to CKB CORE's new home! Please be sure to update any bookmarks you may have.
×

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04296890
Title A Study of Mirvetuximab Soravtansine in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression
Acronym SORAYA
Recruitment Completed
Gender female
Phase Phase III
Variant Requirements No
Sponsors ImmunoGen, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ITA | ESP | DEU | BEL | AUS


No variant requirements are available.